Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/10/2004CN1544631A Dehydrin gene BcDh2 and the application of promoter in cultivation of drought resistant plants
11/10/2004CN1544630A Method for preparing recombinant duck interleukin-2 protein and its application
11/10/2004CN1544629A Method for preparing recombinant goose interleukin-2 protein and its application
11/10/2004CN1544628A Trichina TS88 gene, their protein products and uses
11/10/2004CN1544627A Phase separation method for biomacromolecule components
11/10/2004CN1544626A Method for improving wood drought resistance using transgenic technology
11/10/2004CN1544625A Method for construction of bombyx mori virus fast gene expression system utilizing bacterium transposon
11/10/2004CN1544624A Double promoter DNA vaccine expression vector pCMVnir and preparation method thereof
11/10/2004CN1544620A Method for producing 7-amino cephalosporanic acid and its specific recombinase
11/10/2004CN1544473A Recombinant fusion protein of mycobacterium tuberculosis Ag85B antigen and human IL-2, and its uses
11/10/2004CN1544465A Protein for promoting nerve differentiation and resisting cell death, and its coding gene
11/10/2004CN1544462A Heterologous expression of neisserial proteins
11/10/2004CN1544454A Antisense nucleic acid for multiple drug resistance gene of human epidermis tumor cell
11/10/2004CN1175115C Method for screening transgenic plant and bivalent plant expression vector used in the method
11/10/2004CN1175111C Method for integrating genes at specific sites in mammalian cells and vector used in it
11/10/2004CN1175110C Amidated recombinant polypeptide and its preparation
11/10/2004CN1175109C Expression system for producing recombined human erythrogenin, method for purifying secreted human erythrogenin
11/10/2004CN1175108C Method for production of L-amino acids from their racemic N-acetyl-D,L-derivatives by enzymatic separation of recombinant enzymes
11/10/2004CN1175107C DNA molecules of encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutant thereof
11/10/2004CN1175106C Human insulin recombinant gene, preparation method and application
11/10/2004CN1175104C Endo-beta-N-acetyl glucosaminidase gene
11/10/2004CN1174998C Peptide immunogens for prevention and treatment of allergy
11/10/2004CN1174993C VEGI, an inhibitor for angiogenesis and tumor growth
11/09/2004US6816564 Techniques for deriving tissue structure from multiple projection dual-energy x-ray absorptiometry
11/09/2004US6815594 Inbred corn line G1202
11/09/2004US6815593 Genetic engineered plant; uniform particles
11/09/2004US6815592 Inbred maize line PH3AV
11/09/2004US6815581 Plants which synthesize a modified starch, process for the production thereof and modified starch
11/09/2004US6815580 To improve plant yield by increasing starch biosynthesis; located in chloroplasts in leaves/stems
11/09/2004US6815578 For modulating expression of saccharomyces rad50 gene in transgenic plants; genetic engineering
11/09/2004US6815577 Method of hybrid seed production using conditional female sterility
11/09/2004US6815541 Coprecipitant and method for extracting nucleic acids
11/09/2004US6815540 Improved solubility/yield/ease of handling; fusion proteins; for diagnostics/drugs/research
11/09/2004US6815539 For drug screening potassium channel (slo3) modulators/detection of homologs
11/09/2004US6815538 Human secreted proteins and polynucleotides encoding the same
11/09/2004US6815537 Comprises cloned dna encoding replication protein (rept); used to screen, select and express thermostable proteins without high temperature cultures; genetic engineering
11/09/2004US6815534 Tissue plasminogen activator-like protease
11/09/2004US6815532 For use in cancer therapy
11/09/2004US6815531 For diagnosis/therapy of autoimmune diseases; antitumor agents; drugs; cytotoxic t-lymphocytes
11/09/2004US6815432 Methods for encapsulating plasmids in lipid bilayers
11/09/2004US6815430 Gene expression base sequences for therapeutic use and drugs for gene therapy
11/09/2004US6815429 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
11/09/2004US6815420 Methods of using chemokine beta-6
11/09/2004US6815415 Diagnosis and treatment of malignant neoplasms
11/09/2004US6815205 Auxinic analogues of indole-3-acetic acid
11/09/2004US6815200 Modified adenovirus containing a fiber replacement protein
11/09/2004US6815195 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids
11/09/2004US6815194 Cytidine deaminase
11/09/2004US6815193 Protease for use in treating textiles, cleaning agents and animal feeds
11/09/2004US6815191 Endo-β-N-acetylglucosaminidase gene
11/09/2004US6815190 Having improved thermostability; used in the enzymatic hydrolysis of cyclic oligomers of poly(ethylene terephthalate) in the finishing of yarn or fabric from fibers
11/09/2004US6815189 For the synthesis of deacetylated derivatives; gene expression inhibition
11/09/2004US6815185 Methods of creating constructs useful for introducing sequences into embryonic stem cells
11/09/2004US6815184 Generating preferential polypeptide in plant; obtain plant cells, transform with vector containing preferential polypeptide, express vector, recover polypeptide
11/09/2004US6815183 For preventing infection of mosquitoes/transmission of malaria; drug screening; vaccines
11/09/2004US6815182 For diagnosis/therapy/prophyaxis of infections/diseases; vaccines; genetic engineering
11/09/2004US6815180 Human cervical cancer 1 protooncogene and protein encoded therein
11/09/2004US6815171 Two-domain mhc polypeptides include mhc( major histocompatibility complex) class ii-based molecules that covalently linked beta 1 and alpha 1 domains, and mhc class i-based molecules that covalently linked alpha-1 and alpha-2
11/09/2004US6815167 Amplification of DNA to produce single-stranded product of defined sequence and length
11/09/2004US6815164 Methods and probes for detection and/or quantification of nucleic acid sequences
11/09/2004US6815159 Generation of viral protease; obtain polypeptide, incubate with chaotropic agent, fold, recover protease
11/09/2004US6815158 Evaluation of cattle sensitivity to blood disorders; obtain tissue sample, recover major histocompatibility complex protein, detect valine, glutamine and arginine at specific position, presence indicates resistance to blood defect
11/09/2004US6814969 Epitopes recognized by t-cells (cd-8/cd-4 antigens) derived from herpetic lesions; fusion proteins; antigen presenting cells; vaccines
11/09/2004US6814968 Inhibition of viral infection and spread with viral and RhoA-derived peptides
11/09/2004US6814967 Polypeptides
11/09/2004US6814964 Supramolecules containing binding and therapeutic molecules bound to hybridized nucleic acids
11/09/2004US6814963 Baculovirus-based expression system
11/09/2004US6814962 Defective recombinant adenovirus comprising a nucleic acid sequence coding for a biologically active human lipoprotein lipase
11/09/2004US6814934 Instrument for monitoring nucleic acid amplification
11/09/2004US6814870 Microchip electrospray device and column with affinity adsorbents and use of the same
11/09/2004US6814298 Digital data producing system
11/09/2004CA2426781A1 Bace1 promoter sequences
11/09/2004CA2343358C Cerebral organic anion transporter and its gene
11/09/2004CA2304437C Process for the production of naturally folded and secreted proteins
11/09/2004CA2294475C Recombinant materials and methods for the production of limonene hydroxylases
11/09/2004CA2273080C Mutants of the lag-3 proteins, products for the expression of these mutants and use
11/09/2004CA2151231C Human cyclooxygenase-2cdna and assays for evaluating cyclooxygenase-2 activity
11/09/2004CA2138137C Diphtheria toxin vaccines
11/09/2004CA2035381C Preparation and use of gene banks of human antibodies ("human-antibody libraries")
11/09/2004CA1341464C Hepatitis e, an enterically transmitted hepatitis viral agent
11/04/2004WO2004095216A2 The symmetry relationships between pairs of connectrons
11/04/2004WO2004094674A1 Method of inactivating ribonucleases at high temperature
11/04/2004WO2004094672A1 Methods and devices for removal of organic molecules from biological mixtures
11/04/2004WO2004094654A2 Transfection kinetics and structural promoters
11/04/2004WO2004094643A1 Novel cosmid vector
11/04/2004WO2004094642A2 Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof
11/04/2004WO2004094640A1 Avian transgenesis using a chicken ovalbumin gene region
11/04/2004WO2004094639A2 Recombinant fel d 1 allergen
11/04/2004WO2004094638A1 Vasculitis antigen and method of diagnosing vasculitis
11/04/2004WO2004094637A1 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein
11/04/2004WO2004094636A1 Effective sirna knock-down constructs
11/04/2004WO2004094635A2 Compositions and methods for using a solid support to purify rna
11/04/2004WO2004094634A1 Method of isolating nucleic acid and, for nucleic acid isolation, kit and apparatus
11/04/2004WO2004094633A1 Process for producing recombinant protein in bacterium belonging to the genus rhodococcus
11/04/2004WO2004094632A1 Method of detecting histamine-producing bacterium and primer for use in the method
11/04/2004WO2004094630A1 Insect chymotrypsin and inhibitors thereof
11/04/2004WO2004094628A1 Imanitib-resistant philadelphia chromosome-positive human acute lymphocytic leukemic cell line and utilization thereof
11/04/2004WO2004094627A1 Method for improving germline transmission efficiency of avian primordial germ cells
11/04/2004WO2004094620A2 Truncated baff receptors
11/04/2004WO2004094618A2 Modulation of diacylglycerol acyltransferase 1 expression